España
India
Italia
대한민êµ
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Repligen
RGEN
NASDAQ
Watchlist
Get Report
Perks
Buy
Compare Brokers
$120.82
1.03
0.86%
At Close: -
$120.82
0
0.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Get Report
Watch
Repligen (RGEN) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Repligen (NASDAQ:RGEN) Stock
Repligen Stock (NASDAQ: RGEN)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, June 26, 2024
Repligen shares are trading higher after Deut...
Benzinga Newsdesk
This Robinhood Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday
Avi Kapoor
NVIDIA To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Wednesday
Avi Kapoor
Deutsche Bank Upgrades Repligen to Buy, Lower...
Benzinga Newsdesk
Friday, June 21, 2024
Top 3 Health Care Stocks That Could Blast Off In June
Avi Kapoor
Tuesday, June 18, 2024
Guggenheim Initiates Coverage On Repligen wit...
Benzinga Newsdesk
Thursday, June 13, 2024
Why Signet Jewelers Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
Repligen shares are trading lower after the c...
Benzinga Newsdesk
Repligen Appoints Olivier Loeillot As Chief E...
Benzinga Newsdesk
Monday, June 03, 2024
Ecolab Life Sciences And Repligen Launch DurA...
Benzinga Newsdesk
Thursday, May 02, 2024
JP Morgan Maintains Overweight on Repligen, L...
Benzinga Newsdesk
Wednesday, May 01, 2024
Repligen Reaffirms 2024 Adjusted EPS Guidance...
Benzinga Newsdesk
Repligen Reaffirms 2024 Sales Guidance Of $62...
Benzinga Newsdesk
Repligen Q1 2024 Adj EPS $0.28 Misses $0.30 E...
Benzinga Newsdesk
Tuesday, April 23, 2024
HealthStream Reports Upbeat Results, Joins Spotify, Ryder System And Other Big Stocks Moving Higher On Tuesday
Avi Kapoor
Repligen shares are trading higher as life sc...
Benzinga Newsdesk
Monday, March 25, 2024
Aehr Test Systems Reports Preliminary Results, Joins Dyne Therapeutics, United Airlines And Other Big Stocks Moving Lower On Monday
Avi Kapoor
Wednesday, February 21, 2024
What's Going On With Life Science-Focused Repligen Stock Today?
Vandana Singh
Repligen shares are trading lower after the c...
Benzinga Newsdesk
Repligen Expects Fiscal Year 2024 Adjusted EP...
Benzinga Newsdesk
Repligen Expects Fiscal Year 2024 Revenue Of ...
Benzinga Newsdesk
Repligen Q4 Adjusted EPS $0.33, Inline, Sales...
Benzinga Newsdesk
Earnings Scheduled For February 21, 2024
Benzinga Insights
Thursday, February 15, 2024
Keybanc Maintains Overweight on Repligen, Rai...
Benzinga Newsdesk
Friday, January 26, 2024
Why Intel Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
Booz Allen Hamilton Posts Upbeat Results, Joins AppFolio, Gentex And Other Big Stocks Moving Higher On Friday
Avi Kapoor
Wednesday, December 20, 2023
Analyst Ratings For Repligen
Benzinga Insights
JP Morgan Maintains Overweight on Repligen, R...
Benzinga Newsdesk
Thursday, December 07, 2023
Repligen Announces Private Convertible Transa...
Benzinga Newsdesk
Monday, December 04, 2023
The Latest Analyst Ratings for Repligen
Benzinga Insights
Benchmark Downgrades Repligen to Hold
Benzinga Newsdesk
Friday, November 03, 2023
Expedia Group, Gartner, Cloudflare, Cardinal Health And Other Big Stocks Moving Higher On Friday
Lisa Levin
Thursday, November 02, 2023
Analyst Expectations for Repligen's Future
Benzinga Insights
Repligen Announced The Commercial Launch Of T...
Benzinga Newsdesk
Wednesday, November 01, 2023
Stifel Maintains Buy on Repligen, Lowers Pric...
Benzinga Newsdesk
UBS Maintains Buy on Repligen, Lowers Price T...
Benzinga Newsdesk
Keybanc Maintains Overweight Rating for Repligen: Here's What You Need To Know
Benzinga Insights
RBC Capital Maintains Outperform on Repligen,...
Benzinga Newsdesk
Keybanc Maintains Overweight on Repligen, Low...
Benzinga Newsdesk
Tuesday, October 31, 2023
Why JetBlue Airways Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
Repligen shares are trading higher after the ...
Benzinga Newsdesk
Repligen's Strong Q3 Recovery: CEO Says Pharma Orders Rebound, Analytics Business Grows
Vandana Singh
Arista Networks, JinkoSolar, Repligen, Shutterstock And Other Big Stocks Moving Higher On Tuesday
Lisa Levin
Repligen Expects FY23 Adjusted EPS Of $1.70-$...
Benzinga Newsdesk
Repligen Expects FY23 Revenues Of $635M-$645M...
Benzinga Newsdesk
Repligen Q3 Adjusted EPS $0.23 Beats $0.17 Es...
Benzinga Newsdesk
Earnings Scheduled For October 31, 2023
Benzinga Insights
Monday, October 30, 2023
A Preview Of Repligen's Earnings
Benzinga Insights
Wednesday, October 25, 2023
Shares of healthcare equipment and tools stoc...
Benzinga Newsdesk
Why Owens Corning Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch